Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHRASE: Flurbiprofen + Xilocaine for Endoscopy
NCT06220175Completed
- Sponsor
- Carol Davila University of Medicine and Pharmacy
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of flurbiprofen in upper gastrointestinal endoscopy (2 arms), sponsored by Carol Davila University of Medicine and Pharmacy. Primary endpoint: Patient satisfaction score at 24 hours. Started Mar 2024; status: completed.
02
Drugs
flurbiprofen
03
Conditions
upper gastrointestinal endoscopy
Beyond the preview
Go deeper on NCT06220175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06220175.